+987.9%
MRNA vs NSC
+24.4%
+963.5%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | NSC | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +0.9% | +12.2% | +12.5% |
| 7D | +20.6% | +1.8% | +18.9% | +19.4% |
| 30D | +27.1% | +8.8% | +18.3% | +19.8% |
| 3M | +353.4% | +1.2% | +352.1% | +353.2% |
| 6M | +446.3% | +11.3% | +434.9% | +439.2% |
| YTD | +776.2% | +20.7% | +755.4% | +709.1% |
| 1Y | +987.9% | +23.4% | +964.5% | +839.5% |
| All | +987.9% | +24.4% | +963.5% | +839.5% |
Cumulative growth
Daily Returns
Daily percentage return beside NSC.
Daily Out/Under-Performance
Portfolio return minus NSC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × NSC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded NSC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling